Physician profile
Robert E Hardister
NPI 1083832687
$4,557.77
in general payments reported to CMS, 2019-2025
15 companies · $16.56 in 2025
The $16.56 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $14.46 · 2021: $203 · 2022: $3,641 · 2024: $513 · 2025: $16.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $416 · Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $415.79 |
| Food and Beverage | $113.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,211.69 | 2021-2024 | |
| Smith+Nephew, INC. | $66.63 | 2019-2022 | |
| Allergan, INC. | $52.75 | 2019 | |
| Emd Serono, INC. | $28.80 | 2019 | |
| Livanova USA, INC. | $26.53 | 2019 | |
| Hydrofera LLC | $21.42 | 2024 | Hydrofera Blue |
| Davol INC. | $19.76 | 2022 | |
| Genzyme Corporation | $19.41 | 2019 | |
| Integra Lifesciences Corporation | $18.29 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.69 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.56 | 2025 | Exparel |
| Abbvie INC. | $16.08 | 2022 | |
| Apria Healthcare LLC | $15.78 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.46 | 2020 | |
| Ucb, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hardister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.